Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

595 Articles

Chris Lange | Jan 28, 2019 at 10:10 AM EST

Short Interest Spikes in a Couple Major Pharma Stocks

The January 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jan 25, 2019 at 11:20 AM EST

How AbbVie Tripped Up in Q4

AbbVie shares retreated after it released disappointing fourth-quarter financial results before the markets opened on Friday.

Chris Lange | Jan 11, 2019 at 9:50 AM EST

Major Pharma Sees Fading Short Interest

The December 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Jan 3, 2019 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Agilent, Albermarle, Apple, Boeing, Cheniere, First Solar, HCA, LabCorp, Lumber Liquidators, Teva and More

The top analyst upgrades, downgrades and initiations seen on Thursday included AbbVie, Agilent Technologies, Albermarle, Apple, Boeing, Cheniere Energy, First…

Chris Lange | Dec 27, 2018 at 10:00 AM EST

Short Sellers Hike Bets in Major Pharma Stocks

The December 14 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Dec 12, 2018 at 9:50 AM EST

Major Pharma Stocks See a Surge in Short Interest

The November 30 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Nov 28, 2018 at 9:00 AM EST

Short Sellers Hike Their Bets in Major Pharma Stocks

The November 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Nov 12, 2018 at 10:10 AM EST

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

The October 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Nov 6, 2018 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, AMAG Pharma, Crocs, HCA, Kellogg, Kosmos Energy, Mylan, Pandora, Square and More

The top analyst upgrades, downgrades and initiations seen on Tuesday included AbbVie, AMAG Pharmaceuticals, Crocs, HCA, Kellogg, Kosmos Energy, Mylan,…

Chris Lange | Nov 2, 2018 at 10:23 AM EDT

AbbVie Little Changed Despite Big Bottom-Line Beat

AbbVie released its third quarter financial results before the markets opened on Friday. The pharma giant said that it had…

Paul Ausick | Nov 1, 2018 at 2:08 PM EDT

Encana, Hanesbrands Sink into Thursday’s 52-Week Low Club

Encana, Hanesbrands, Abbvie, and Annaly Capital Management all posted new 52-week lows Thursday.

Chris Lange | Oct 25, 2018 at 9:00 AM EDT

Major Pharma Short Sellers Hike Their Bets

The October 15 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Oct 25, 2018 at 7:10 AM EDT

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

These four top pharmaceutical companies have longstanding franchises with huge sales and revenues, and their dividend-paying stocks look like outstanding choices…

Chris Lange | Oct 10, 2018 at 9:10 AM EDT

Short Sellers Run for Cover From Major Pharma

The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Oct 4, 2018 at 12:10 PM EDT

Rising Interest Rates and All, 13 Blue Chips Outyield 10-Year and 30-Year Treasuries

Here are 13 companies with solid dividends that currently yield more than both the 10-year Treasury note and the 30-year…

1 … 18 19 20 21 22 … 40

AbbVie : ABBV

All AbbVie Articles

Short Interest Spikes in a Couple Major Pharma Stocks

How AbbVie Tripped Up in Q4

Major Pharma Sees Fading Short Interest

Top Analyst Upgrades and Downgrades: AbbVie, Agilent, Albermarle, Apple, Boeing, Cheniere, First Solar, HCA, LabCorp, Lumber Liquidators, Teva and More

Short Sellers Hike Bets in Major Pharma Stocks

Major Pharma Stocks See a Surge in Short Interest

Short Sellers Hike Their Bets in Major Pharma Stocks

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

Top Analyst Upgrades and Downgrades: AbbVie, AMAG Pharma, Crocs, HCA, Kellogg, Kosmos Energy, Mylan, Pandora, Square and More

AbbVie Little Changed Despite Big Bottom-Line Beat

Encana, Hanesbrands Sink into Thursday’s 52-Week Low Club

Major Pharma Short Sellers Hike Their Bets

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

Short Sellers Run for Cover From Major Pharma

Rising Interest Rates and All, 13 Blue Chips Outyield 10-Year and 30-Year Treasuries

Prediction: Eli Lilly Will Trade at $1,200 on This Date

The Retirement Portfolio That Forks Over a $10,000 Check Every Month

A $850,000 Portfolio That Quietly Pays You $51,000 a Year Without Touching Principal

The Retirement Portfolio That Forks Over a $10,000 Check Every Month

A $850,000 Portfolio That Quietly Pays You $51,000 a Year Without Touching Principal

Prediction: Eli Lilly Will Trade at $1,200 on This Date

The Retirement Portfolio That Forks Over a $10,000 Check Every Month

AbbVie : ABBV

All AbbVie Articles

Short Interest Spikes in a Couple Major Pharma Stocks

How AbbVie Tripped Up in Q4

Major Pharma Sees Fading Short Interest

Top Analyst Upgrades and Downgrades: AbbVie, Agilent, Albermarle, Apple, Boeing, Cheniere, First Solar, HCA, LabCorp, Lumber Liquidators, Teva and More

Short Sellers Hike Bets in Major Pharma Stocks

Major Pharma Stocks See a Surge in Short Interest

Short Sellers Hike Their Bets in Major Pharma Stocks

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

Top Analyst Upgrades and Downgrades: AbbVie, AMAG Pharma, Crocs, HCA, Kellogg, Kosmos Energy, Mylan, Pandora, Square and More

AbbVie Little Changed Despite Big Bottom-Line Beat

Encana, Hanesbrands Sink into Thursday’s 52-Week Low Club

Major Pharma Short Sellers Hike Their Bets

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

Short Sellers Run for Cover From Major Pharma

Rising Interest Rates and All, 13 Blue Chips Outyield 10-Year and 30-Year Treasuries

Prediction: Eli Lilly Will Trade at $1,200 on This Date

The Retirement Portfolio That Forks Over a $10,000 Check Every Month

A $850,000 Portfolio That Quietly Pays You $51,000 a Year Without Touching Principal

Featured Reads

The Retirement Portfolio That Forks Over a $10,000 Check Every Month

A $850,000 Portfolio That Quietly Pays You $51,000 a Year Without Touching Principal